Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Autor: | Garg, Satish K., Liljenquist, David, Bode, Bruce, Christiansen, Mark P., Bailey, Timothy S., Brazg, Ronald L., Denham, Douglas S., Chang, Anna R., Akturk, Halis Kaan, Dehennis, Andrew, Tweden, Katherine S., Kaufman, Francine R. |
---|---|
Zdroj: | Diabetes Technology & Therapeutics; Feb2022, Vol. 24 Issue 2, p84-92, 9p |
Databáze: | Complementary Index |
Externí odkaz: |